Introduction
Self-tolerance is a multistage process, which is progressively established during T cell development in the thymus, and which is maintained throughout the lifespan of mature T cells in the periphery. Much of the initial concepts on T cell tolerance emerged from studying the biology of superantigens (SAgs) in mice.
1;2 SAgs stimulate 10 3 -10 5 more T cells than conventional antigens, a feature that is based on the capacity to selectively bind Vβ chains on T cells in a variety of different modes indiscriminately of their antigen specificity. 3 Infectious and endogenous mouse mammary tumor viruses (MMTVs) encode several SAgs with different TCR Vβ specificities. 4;5 Multiple forms of T cell tolerance to these SAgs develop; negative selection in the thymus is one of the most extensively studied. It results in a partial or complete deletion of mature T cells expressing SAg reactive Vβ chains from the peripheral repertoire. 6 Thymic deletion reflects the susceptibility of immature, and semi-mature thymocytes to undergo negative selection at the corticomedullary junction and in the thymic medulla replete of professional antigen presenting cells (APCs). 7;8 It requires that SAg expression exceeds a threshold level during thymocyte development, 9;10 and that SAgs are presented by the appropriate thymic cell type, which includes medullary epithelial cells and haematopoietic APCs.
11
Expression of some MMTV SAgs is restricted to the thymocyte lingeage, 12 and efficient deletion in these instance relies on paracrine transfer to MHC class II + thymic APCs. 13;14 SAg induced central tolerance therefore depends both on the developmental stage of the reactive thymocytes, and on the temporo-spatial regulation of SAg expression. The primary failure to eliminate self-reactive thymocytes can result in organ-specific autoimmunity, 15 which illustrates the importance of the thymus for organ-specific tolerance.
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The HERV-K18 envelope gene on chromosome 1 encodes for a SAg stimulating Vβ7 and Vβ13 T cells 16 that is implicated in the establishment of Epstein Barr virus (EBV) persistence 17 , and in type 1 diabetes (T1D). For instance, HERV-K18 polymorphisms are associated with T1D. 18 Particularly Vβ7, and to a lesser extent Vβ13 T cells, are enriched in the inflammatory lesions 19;20 and in the circulation 21 of patients at the clinical onset of T1D. HERV-K18 transcription and SAg function in cells efficiently presenting SAgs are inducible by proinflammatory stimuli such as viral infection 22 and interferon-α (IFN-α). 23 This provides an attractive model linking infection with the initiation or progression of autoimmunity.
Here we explored the mechanisms governing central T cell tolerance to the HERV-K18 SAg. We found that thymic HERV-K18 SAg expression is constitutive, and restricted in time and space such that it can induce negative selection. The
HERV-K18
SAg is necessary and sufficient for negative selection of immature or semimature Vβ7CD4 thymocytes. Our data are consistent with the notion that the peripheral levels of Vβ7CD4 T cells are predictive of SAg reactivity. It poses the premises to exploit the role of HERV-K18 induced negative selection for tolerance and autoimmunity in humans.
Methods

Molecular cloning, ribonuclease protection analysis (RPA)
The frame-shift mutant ∆53 was generated by AvrII digestion and fill in of the HERV-K18.1 SAg. RPA analysis was performed on ~25 µg total RNA of whole tissue samples, or FACS sorted cell suspensions using previously described probes. 23 The mouse TATA Binding Protein (mTBP) probe protected a 160 bp fragment, the SAg probe protected a 299 bp fragment from ∆53 based constructs, and a 324 bp fragment from wt SAg based constructs.
Purification of thymocyte subsets and FACS analysis
DP thymocytes were pre-enriched by targeting the CD1 + subset with biotinylated anti-CD1A antibodies and streptavidin-coated paramagnetic microbeads, followed by magnetic sorting (Miltenyi Biotec, Bergisch Gladbach, Germany). The positive fraction was further labeled with CD8-APC and sorted on a flow cytometer to eliminate the contaminating CD8 -immature CD4SP cells. The final purity of the DP cells was >98%.
FACS analysis of thymoyte subsets was performed on freshly isolated cells. Invention (Dr. X-H. Li, UT Southwestern at Dallas). They were used at 1:100, and were revealed with FITC-coupled secondary antibodies (Pharmingen).
HERV-K18 transfectants
Bulk transfectants of A20 (TIB-208) were generated by electroporation of a SRα promoter driven bicistronic EGFP expression cassette, 23 and were maintained at 1-2 
Thymocyte assays
Single cell suspensions of freshly isolated human thymocytes were obtained from children undergoing cardiac surgery as described. 24 For consistent biological behavior, samples i), from donors <1 month, ii), with <70% DP thymocytes, and iii), with CD8 SP values equaling or exceeding those of CD4 SP were excluded.
Thymocytes were analyzed by FACS, after culture for 24 or 48 h at 37 o C, with Mitomycin C inactivated, and PMA (50 ng ml -1 for 16h at 37 o C) treated APCs, at the indicated ratios. Before analysis, cell suspensions were EDTA treated to avoid clustering of thymocytes with APCs; dead cells were excluded by PI staining.
Mature T cell expansions assays
Assays were performed with FACS sorted A20 clones with low SAg expression for most efficient SAg presentation. After 3 days in 96 wells at the indicated stimulator to
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Blood donors
Twenty-four healthy donors were from the blood bank in Geneva, 18 from the blood bank in Lausanne (55±13years), and 18 (28±4years) were volunteers from the Dept.
of Genetics & Microbiology.
Results
Constitutive thymic HERV-K18 SAg expression
An absolute requirement for deletion of SAg reactive thymocytes in vivo is thymic HERV-K18 SAg expression. We indeed found significant levels of HERV-K18 SAg transcripts in total thymus tissue and thymocyte suspensions from all donors analyzed (n=5, Figure 1A ). As compared to the loading control TBP, some variation in individual HERV-K18 expression levels was observed. Thymic HERV-K18 protein expression and its variability were corroborated by FACS analysis on thymocyte suspensions using monoclonal anti-HERV-K18 antibodies (n=4, Figure 1B ). The levels of HERV-K18 cell surface expression matched that of another wellcharacterized endogenous retroviral envelope protein constitutively expressed in the placenta. 25 HERV-K18 exists as three alleles, encoding secreted-or cell surface membrane-proteins. The surface protein complexes are unstable, and are shed from cells. 26 Thus, in all cases the SAg can become available for presentation by MHC class II in trans.
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Constitutive HERV-K18 expression in the thymocyte lineage implied that it had to be shut down later during development, since the SAg is not constitutively expressed in mature T cells. 23 This is effectively the case, as can be seen in Figure   1C . Interestingly, SAg transcription is restricted to immature double positive (DP)
thymocytes, but it is neither expressed in the immediate precursors of DP cells 
An in vitro assay for negative selection induced by soluble bacterial SAgs
We first developed an in vitro assay with freshly isolated human thymocytes and extrathymic APCs, analogously to one of the first systems for negative selection developed in mice. 28 It was capable of specifically detecting deletion of immature As anticipated, the percentages of DP thymocytes, and their CD4/CD8 expression decreased in a SAg dose dependent fashion as compared to control transfectants, consistent with SAg induced negative selection ( Figure 3A) . This was
For personal use only. on November 12, 2017. by guest www.bloodjournal.org From paralleled by significant and specific reductions in absolute thymocyte numbers, as shown in the suppl. Figure 1 , corroborating HERV-K18 SAg induced negative selection. Additional evidence supported the notion that the decrease in DP thymocytes was the consequence of cell death. Firstly, since only immature DP and semimature CD4SP thymocytes, but non mature SP thymocytes are known to be deletion-sensitive, we confirmed that purified immature DP (suppl. Figure 2A Deletion of thymocytes sensitive to negative selection was SAg dependent, firstly, because the frameshift mutation that truncates the SAg after 53 N-terminal amino acids (K18.1∆53) completely abolished its capacity to delete ( Figure 3B ). This was not due to a loss of protein stability, since ∆53 mutant transcripts and protein accumulated to levels comparable to that of the wt SAg (suppl. Figure 2B When the Vβ usage of DP and SP thymocytes was analyzed after culture with SAg transfectants, Vβ7 was in general more strongly reduced than control Vβs ( Figure 3C ). Negative selection of Vβ7 was most manifestly affecting CD4 thymocytes, when the specificity (P<0.05, Figure 3D) , and the extent of the deletion (P<0.01, Figure 3C ), were taken into consideration jointly. This is consistent with HERV-K18 induced deletion affecting primarily semimature CD4SP cells, analogously to MMTV SAgs. 7 From these experiments we conclude that the HERV-K18 SAg predominantly deletes semimature CD4SP or immature DP thymocytes carrying Vβ7 chains.
Vβ7CD4 T cell levels predict HERV-K18 SAg reactivity
To be able to causally relate peripheral T cell levels with SAg reactivity, we first sought to establish a link between intrathymic and peripheral Vβ7CD4 cell levels, and subsequently with SAg reactivity. The central premise was that if negative selection to HERV-K18 affected primarily Vβ7CD4 thymocytes, then low peripheral Vβ7CD4 levels would predict weak or absent SAg reactivity. To explore this, we compared the thymic and peripheral repertoire of three Vβ families that are heterogeneously distributed in the CD4/CD8 subsets. This analysis confirmed and extended the notion that these distributions are generated intrathymically, and maintained in the periphery. In fact, while Vβ2 expression was skewed towards CD4 usage in the thymus and peripheral T cells, Vβ7 was variably reduced among CD4 cells, and Vβ17
was evenly distributed among subsets in both anatomical locations ( Figure 4A+4B ). Figure 4D ).
Differential peripheral SAg responsiveness was consistently associated with individuals of either group -expander versus weak-expander -when analyzed periodically (Suppl. Figure 3) , and was confirmed for 14 additional healthy blood donors (not shown). These results are consistent with the idea that low thymic and peripheral Vβ7CD4 T levels predict absent or diminished peripheral SAg reactivity, and conversely high thymic and peripheral Vβ7CD4 T levels predict strong peripheral SAg reactivity.
T cell anergy is unlikely accounting for the differential peripheral SAg reactivity
We wished to exclude that other tolerance mechanisms could account to a significant extent for the differential peripheral T cell reactivity. Anergic T cells both in mice and men do not proliferate or secrete IL-2, and do not progress through the cell cycle
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SAg stimulated Vβ7CD4 T cells in weak responders were blocked in the G1 phase of the cell cycle. This was clearly not the case. As can be seen in Figure 5 , While we cannot completely rule out a contribution of anergy to peripheral SAg reactivity, this appears to be unlikely. We therefore conclude that the differences between strongly and weakly expanding Vβ7CD4 T cells is T cell autonomous and qualitative, and is by all criteria addressed here more accurately explained by thymic deletion than T cell anergy. We hence propose that thymic deletion affects primarily Vβ7CD4 thymocytes, and determines weak SAg reactivity via reducing the peripheral Vβ7CD4 levels.
Discussion
Our results show that transcriptional regulation of HERV-K18 expression in the thymus is such that HERV-K18 SAgs can induce negative selection in vivo, and that the HERV-K18 SAg is necessary and sufficient for negative selection of immature or semimature Vβ7 thymocytes, affecting primarily Vβ7CD4 cells. The data are further
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show that reduced thymic and peripheral levels of Vβ7CD4 T cells predict low or absent SAg reactivity. HERV-K18 can therefore be exploited to study central tolerance and its potential role for viral persistence and autoimmunity in humans.
Our data fits best a model stipulating that HERV-K18 induced negative selection in vivo primarily affects Vβ7CD4 thymocytes, by acting via the deletionsensitive semimature CD4SP thymocytes, analogously to MMTV SAgs. We have however, not addressed this directly in the present manuscript. This scenario is also closest to our observation that peripheral Vβ7CD4 T cells are variably reduced, and that low proportions predict weak SAg reactivity.
The model system presented here is a first step towards dissecting the complexity of negative selection in humans. It needs to be stepwise expanded to account for HERV-K18-, 23 MHC class II-, 29 and TCR-polymorphisms 36 that are all anticipated to modulate thymocyte deletion. This can only be achieved once the genetic and biochemical interactions of variants at these three loci have been defined, which is far beyond the scope of the present study. that can give rise to thymocytes plus APCs capable of negative selection. 38 The latter
will allow us to demonstrate the causality of the HERV-K18 genotype on the T cell repertoire by knocking it down with RNA interference.
In sum, we propose that HERV-K18 SAg induced negative thymocyte selection is operational also in vivo. Analysis of the mature human T cell repertoire is indeed consistent with this view. Healthy individuals have variably reduced peripheral Vβ7CD4 T cell levels 39;40 that are predictive of SAg reactivity, and that are therefore possibly due to partial negative selection by HERV-K18 SAgs. We therefore propose that negative thymic selection to HERV-K18 SAgs is a first checkpoint controlling peripheral tolerance versus SAg reactivity. Gating on thymocyte subsets was based on CD4/CD8 expression, and exclusion of dead cells, which allowed to us address HERV-K18 expression of thymocyte subsets. 
